The objective of this study is to evaluate the performance, usability, and result interpretation of the INSTIĀ® HIV Self-Test (referred to INSTIĀ® HIV ST) in the intended use population across the United States (US). The INSTIĀ® HIV Self-Test is a single use in vitro test that is used as a self-test for the detection of antibodies to HIV-1 and HIV-2 in human fingerstick blood. This study is designed to evaluate INSTIĀ® HIV ST performance in the hands of non-professionals and untrained lay users who are inexperienced in HIV blood-based self-testing. The study aims to: To evaluate the clinical performance (i.e., diagnostic sensitivity and specificity) of the INSTIĀ® HIV Self-Test in a lay user population. To assess the user's comprehension of the INSTIĀ® HIV ST results (e.g., interpreting positive, negative, and invalid results). To evaluate the usability of the INSTIĀ® HIV ST and understand users' experience in performing the test.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical sensitivity and specificity of the INSTIĀ® HIV Self-Test
Timeframe: 12 Months